Crunchbase News
JANUARY 10, 2025
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. Aviceda Therapeutics , $208M, biotech: It may be a new year, but biotech is still raising big. went, of course, to another biotech firm. went, of course, to another biotech firm.
TechCrunch
FEBRUARY 25, 2023
Biotech was one of the most fortunate. Those figures fell short of the 1,415 biotech deals struck in 2021 worth a total of $39 billion. Compared to 2020’s more conservative 1,143 biotech deals worth $29.6 biotech deals also set new records in 2022 for both median deal size, $33.5 The sector recorded 1,054 U.S.-based
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
N2Growth Blog
OCTOBER 23, 2023
Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.
TechCrunch
APRIL 8, 2022
“In short, it covers just about every aspect of travel IT imaginable,” writes enterprise reporter Ron Miller. 6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. Image Credits: Bryce Durbin/TechCrunch.
Ooda Loop
FEBRUARY 7, 2025
Chinas Ministry of Commerce announced on Tuesday the inclusion of a major US biotech company on its unreliable entity list while stating that the firms discriminatory measures against Chinese enterprises harmed the legitimate rights and interests of Chinese companies.
Crunchbase News
MARCH 4, 2025
Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025. The round is the second biggest for a biotech startup this year, behind only London-based Verdiva Bio , a company creating treatments for obesity and cardiometabolic diseases that raised a $411 million Series A in January.
TechCrunch
SEPTEMBER 13, 2022
Improving the diversity of global genomic data could hasten medical breakthroughs — and that’s the goal of Gen-t , a Brazilian startup working to infuse biotech with genetic data from the country’s population. Currently the company is looking for participants 45 years of age or older.
Expert insights. Personalized for you.
117 
Let's personalize your content